| Interleukin-2 and regulatory T cells in graft-versus-host disease J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ... New England Journal of Medicine 365 (22), 2055-2066, 2011 | 1246 | 2011 |
| Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials J Koreth, R Schlenk, KJ Kopecky, S Honda, J Sierra, BJ Djulbegovic, ... Jama 301 (22), 2349-2361, 2009 | 1115 | 2009 |
| Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library JF Rual, J Ceron, J Koreth, T Hao, AS Nicot, T Hirozane-Kishikawa, ... Genome research 14 (10b), 2162-2168, 2004 | 1087 | 2004 |
| Ipilimumab for patients with relapse after allogeneic transplantation MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ... New England Journal of Medicine 375 (2), 143-153, 2016 | 583 | 2016 |
| Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation P Armand, HT Kim, CS Cutler, VT Ho, J Koreth, EP Alyea, RJ Soiffer, ... Blood 109 (10), 4586-4588, 2007 | 542 | 2007 |
| Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease K Matsuoka, J Koreth, HT Kim, G Bascug, S McDonough, Y Kawano, ... Science translational medicine 5 (179), 179ra43-179ra43, 2013 | 523 | 2013 |
| Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation R Bejar, KE Stevenson, B Caughey, RC Lindsley, BG Mar, P Stojanov, ... Journal of clinical oncology 32 (25), 2691-2698, 2014 | 459 | 2014 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015 | 432 | 2015 |
| Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ... Journal of Clinical Oncology 35 (14), 1598-1605, 2017 | 412 | 2017 |
| A disease risk index for patients undergoing allogeneic stem cell transplantation P Armand, CJ Gibson, C Cutler, VT Ho, J Koreth, EP Alyea, J Ritz, ... Blood, The Journal of the American Society of Hematology 120 (4), 905-913, 2012 | 399 | 2012 |
| Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic … SJ Lee, D Wolff, C Kitko, J Koreth, Y Inamoto, M Jagasia, J Pidala, ... Biology of Blood and Marrow Transplantation 21 (6), 984-999, 2015 | 377 | 2015 |
| Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease S Sarantopoulos, KE Stevenson, HT Kim, CS Cutler, NS Bhuiya, ... Blood, The Journal of the American Society of Hematology 113 (16), 3865-3874, 2009 | 372 | 2009 |
| Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation C Cutler, P Multani, D Robbins, HT Kim, T Le, J Hoggatt, LM Pelus, ... Blood, The Journal of the American Society of Hematology 122 (17), 3074-3081, 2013 | 353 | 2013 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of clinical trials working group report PJ Martin, D Weisdorf, D Przepiorka, S Hirschfeld, A Farrell, JD Rizzo, ... Biology of Blood and Marrow Transplantation 12 (5), 491-505, 2006 | 335* | 2006 |
| Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international … J Koreth, J Pidala, WS Perez, HJ Deeg, G Garcia-Manero, L Malcovati, ... Journal of clinical oncology 31 (21), 2662-2670, 2013 | 322 | 2013 |
| High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized … J Koreth, CS Cutler, B Djulbegovic, R Behl, RL Schlossman, NC Munshi, ... Biology of Blood and Marrow Transplantation 13 (2), 183-196, 2007 | 311 | 2007 |
| Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation K Matsuoka, HT Kim, S McDonough, G Bascug, B Warshauer, J Koreth, ... The Journal of clinical investigation 120 (5), 1479-1493, 2010 | 289 | 2010 |
| Autologous transplantation, consolidation, and maintenance therapy in multiple myeloma: results of the BMT CTN 0702 trial EA Stadtmauer, MC Pasquini, B Blackwell, P Hari, A Bashey, S Devine, ... Journal of clinical oncology 37 (7), 589-597, 2019 | 254 | 2019 |
| Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc … J Bolaños-Meade, R Reshef, R Fraser, M Fei, S Abhyankar, Z Al-Kadhimi, ... The Lancet Haematology 6 (3), e132-e143, 2019 | 243 | 2019 |
| Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation C Cutler, S Li, VT Ho, J Koreth, E Alyea, RJ Soiffer, JH Antin Blood 109 (7), 3108-3114, 2007 | 236 | 2007 |
stefanie SarantopoulosProfessor in Medicine, Professor of Immunology, Duke University在 duke.edu 的电子邮件经过验证
